Neuromodec list of top most impactful Neuromodulation articles for 2021 is now live! Browse all highlights

Neuromodulation applications for COVID-19 disorders

Latest Updates, and Resources


Share |

ABOUT LONG COVID LATEST UPDATES CLINICAL TRIALS

Latest Updates





Update 2
NYU Langone launches an entirely
home-based telemedicine neuromodulation treatment for a range of neurological disorders including Long-Covid. This treatment is based around transcranial Direct Current Stimulation. You can learn more and access treatment here.
Published on: May 30th, 2021

Update 1
Medical University of South Caroline and
Soterix Medical announce a new clinical trial of home-based auricular Vagus Nerve Stimulation (taVNS) for individuals who experience post-COVID neuropsychiatric symptoms, like fatigue, headache, or anxiety. Mark George, a leader in neuromodulation and co-leader of the trial says “When your body tries to fight off COVID… an inflammatory cascade that can kick in… A lot of people feel that the inflammation is what’s causing those symptoms to occur post-COVID. If we can reduce inflammation [with taVNS neuromodulation], we have a chance of reducing that.” Learn more and sign up here
Published on: November 16, 2020




Subscribe to stay up to date about the latest in Neuromodulation